Send the following on WhatsApp
Continue to ChatNine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG) - https://avesis.acibadem.edu.tr/yayin/a2b35233-f7a1-478e-9c3a-a4025275ecc5/nine-weeks-versus-1-year-adjuvant-trastuzumab-in-patients-with-early-breast-cancer-an-observational-study-by-the-turkish-oncology-group-tog